Search
Menu
Zurich Instruments AG - Lock-In Amplifiers 4/24 LB

FDA

Facebook X LinkedIn Email
The FDA has approved the CustomVue monovision lasik device from AMO/Visx Inc. of Santa Clara, Calif. The product is designed to fully correct nearsightedness in the patient’s dominant eye but only partially correct it in the nondominant one, allowing patients to view both nearby and distant objects after an adjustment period. In contrast to traditional lasik, the procedure may reduce the need for patients over the age of 40 to wear reading glasses.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: September 2007
    BiophotonicsFDALASIKNews & Features

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.